Designing peptide vaccines to broaden recognition and enhance potency.
Berzofsky
J A
JA
Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
D016915:AIDS Vaccines / Q000276:immunology*; D000595:Amino Acid Sequence; D000914:Antibodies, Viral / Q000096:biosynthesis; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D015195:Drug Design; D018604:Epitope Mapping; D015686:Gene Products, env / Q000276:immunology*; D019302:HIV Envelope Protein gp160; D006801:Humans; D007111:Immunity, Cellular; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology*; D011498:Protein Precursors / Q000276:immunology*; D013329:Structure-Activity Relationship; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D016915:AIDS Vaccines; D000914:Antibodies, Viral; D015686:Gene Products, env; D019302:HIV Envelope Protein gp160; D010455:Peptides; D011498:Protein Precursors